维存品牌怎么样 申请店铺

我要投票 维存在叶酸行业中的票数:337 更新时间:2025-08-06
维存是哪个国家的品牌?「维存」是杏辉天力(杭州)药业有限公司旗下著名品牌。该品牌发源于台湾,由创始人王昭日在1995-06-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力维存品牌出海!将品牌入驻外推网,定制维存品牌推广信息,可以显著提高维存产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

维存怎么样

杏辉天力(杭州)药业有限公司隶属于台湾上市公司杏辉医药集团,是杏辉集团较大的境外投资。2001年在杏辉董事会,“ 布局全球, 跨足国际, 发展全球策略及远景 “ 之指导方针下,杏辉天力药业创建于浙江省杭州市余杭区。初期厂址位于杭州市老余杭,后配合政府规划,搬迁至杭州市临平城区余杭经济开发区现址。

杏辉天力药业目前主业在天然植物提取物,植物营养素,有机种植规划、农场管理及中草药。乃一以研发为导向之创新型公司。拥有多项国内外产品专利,员工约170人。生产设备为一现代化药品级GMP,及ISO认证之自动化专业工厂。 厂房距临平中心约2公里,东邻新颜港,西邻红丰路,南靠北沙路,交通便利,水、电、汽、排污等配套设施齐全,占地面积为79亩。因应业务不断成长,公司于2017年完成新现代化植提多功能厂房三座,将成为大中华区生技业界具市场竞争力之生产基地。

杏辉天力旗下并拥有一个位于新疆于田县之大型有机种植基地及其所属公司,和田天力沙生药物开发有限责任公司,专司药材供给及种植。核心工作团队整合种植、 研发、 临床、法规、 制造、专利、商务、及相关供应炼等。

杏辉天力药业其它的生产经营范围尚有:生产西药、中成药、原料药;并开发和生产保健品。剂型含盖药品液体、胶囊、胶衣锭、颗粒、粉剂等多项。公司设有严格的品管制度,并按照G.M.P.的要求生产并提供给消费者放心之产品。 杏辉天力药业为杭州市余杭区重点骨干企业。公司将本着一贯〝诚信、务实、创新〞的企业精神,为客户及终端消费者提供良好的服务及高质量的产品.

专业及服务

杏辉天力药业团队实力坚强,拥有各类植化、植提、药学、医学、中西药品、保健食品、食品、营养、国贸、市场营销等人才。博、硕士及大学本科以上专业人员占公司所有人力约50%以上。提供之专业服务以满足客户需求为导向,有效结合种植、研发、临床、法规、制造、专利、及相关供应炼成本会计及业务等面向,有效整合及执行工作。


Xinghui Tianli (Hangzhou) Pharmaceutical Co., Ltd. belongs to Xinghui Pharmaceutical Group, a listed company in Taiwan, which is a large overseas investment of Xinghui group. In 2001, Xinghui Tianli Pharmaceutical Co., Ltd. was founded in Yuhang District, Hangzhou City, Zhejiang Province, under the guidance of the board of directors of Xinghui, "global layout, cross international development, global strategy and vision". The initial site is located in old Yuhang, Hangzhou, and then moved to the current site of Yuhang Economic Development Zone, Linping City, Hangzhou, in cooperation with the government planning. At present, Xinghui Tianli pharmaceutical is mainly engaged in natural plant extracts, plant nutrients, organic planting planning, farm management and Chinese herbal medicine. Is a R & D-oriented innovation company. With a number of domestic and foreign product patents, about 170 employees. The production equipment is a modern GMP and ISO certified automation factory. The plant is about 2km away from Linping center, adjacent to xinyangang in the East, Hongfeng road in the west, Beisha road in the south, with convenient transportation, complete water, electricity, gas, sewage and other supporting facilities, covering an area of 79mu. In response to the continuous growth of business, the company completed three new modern multi-functional plants in 2017, which will become a production base with market competitiveness in the biotechnology industry in Greater China. Xinghui Tianli owns a large-scale organic planting base and its affiliated company located in Yutian County, Xinjiang, and Hotan Tianli ShaSheng Pharmaceutical Development Co., Ltd., which specializes in the supply and planting of medicinal materials. The core team integrates planting, R & D, clinical, regulatory, manufacturing, patent, business, and related supply chain. Other production and business scope of Xinghui Tianli Pharmaceutical Co., Ltd. include: production of Western medicine, Chinese patent medicine and API; and development and production of health products. The dosage form includes liquid, capsule, gel coated ingot, granule, powder, etc. The company has strict quality control system, and according to the requirements of g.m.p. to produce and provide consumers with products at ease. Xinghui Tianli pharmaceutical is a key backbone enterprise in Yuhang District, Hangzhou. The company will, in line with the enterprise spirit of "integrity, pragmatism and innovation", provide customers and end consumers with good services and high-quality products. The professional and service team of Xinghui Tianli pharmaceutical industry is strong, with all kinds of talents in planting, planting, medicine, medicine, Chinese and Western medicine, health food, food, nutrition, international trade, marketing, etc. More than 50% of the company's personnel are professionals with bachelor's degree, master's degree and above. The professional services provided are oriented to meet the needs of customers, and effectively integrate and implement the work in combination with planting, R & D, clinical, regulatory, manufacturing, patent, and related supply refining cost accounting and business.

本文链接: https://brand.waitui.com/019c01f13.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

Palantir季度营收首破10亿美元大关,上调2025全年业绩指引

数据挖掘公司Palantir在人工智能热潮中再创佳绩:季度营收首次突破10亿美元大关,同比激增48%至10亿美元;调整后每股收益0.16美元,两项数据均超市场预期。公司同时将2025全年营收预期上调至41.42-41.50亿美元,显著高于此前指引。(新浪财经)

53分钟前

特朗普:将在未来24小时内大幅提高印度关税

据报道,美国总统特朗普表示,将在未来24小时内大幅提高印度关税。(界面)

53分钟前

美股大型科技股盘前多数上涨,亚马逊涨0.67%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,亚马逊涨0.67%,微软涨0.54%,英伟达涨0.37%,特斯拉涨0.23%,苹果涨0.21%,奈飞涨0.16%,谷歌涨0.14%;Meta跌0.05%。

53分钟前

热门中概股美股盘前多数上涨,哔哩哔哩涨超3%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,哔哩哔哩涨超3%,理想汽车涨超2%,蔚来、网易、富途控股、腾讯音乐涨超1%,小鹏汽车涨近1%;京东跌0.73%,百度跌0.43%。

53分钟前

石药集团:司美格鲁肽注射液上市申请获国家药监局受理

36氪获悉,石药集团发布公告,附属公司石药集团百克(山东)生物制药股份有限公司开发的司美格鲁肽注射液的上市申请已获国家药品监督管理局受理。本次申报的适应症为成人2型糖尿病患者的血糖控制。

53分钟前

本页详细列出关于维存的品牌信息,含品牌所属公司介绍,维存所处行业的品牌地位及优势。
咨询